| Literature DB >> 7562141 |
R G Lastrapes1, J R Parker, M Kida.
Abstract
As the fourth leading cause of cancer death in the United States, pancreatic adenocarcinoma is both a diagnostic and a therapeutic challenge. Its incidence has risen in the past four decades so that pancreatic cancer ranks second to colon cancer as a leading cause of death from gastrointestinal malignancy. Despite technical and therapeutic advances, the prognosis remains dismal; the average survival time after diagnosis is characteristically only five to eight months. The current patient had a pancreatic adenocarcinoma that mimicked other disorders. Variability in clinical presentation and imaging studies warrants consideration of this entity in the differential diagnoses of many splenic and pancreatic lesions.Entities:
Mesh:
Year: 1995 PMID: 7562141
Source DB: PubMed Journal: J Okla State Med Assoc ISSN: 0030-1876